PCN51 Comprehensive Investigation of Adverse Event (AE)-Related Costs in Patients With Metastatic Breast Cancer (mBC) Treated With First- and Second-Line Chemotherapies
| Autor: | Hurvitz, S.A., Guerin, A., Brammer, M., Guardino, E., Zhou, Z.Y., Kaminsky, M.S., Wu, E.Q., Lalla, D. |
|---|---|
| Zdroj: | In Value in Health November 2012 15(7):A418-A418 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect